Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data
Jones, Hannah M, Barton, Hugh A, Lai, Yurong, Bi, Yi-An, Kimoto, Emi, Kempshall, Sarah, Tate, Sonya C, El-Kattan, Ayman, Houston, J Brian, Galetin, Aleksandra, Fenner, Katherine S
Published in Drug metabolism and disposition (01.05.2012)
Published in Drug metabolism and disposition (01.05.2012)
Get full text
Journal Article
Semi-Mechanistic Pharmacokinetic/Pharmacodynamic Modeling of the Antitumor Activity of LY2835219, a New Cyclin-Dependent Kinase 4/6 Inhibitor, in Mice Bearing Human Tumor Xenografts
TATE, Sonya C, SHUFEN CAI, AJAMIE, Rose T, BURKE, Teresa, BECKMANN, Richard P, CHAN, Edward M, DE DIOS, Alfonso, WISHART, Graham N, GELBERT, Lawrence M, CRONIER, Damien M
Published in Clinical cancer research (15.07.2014)
Published in Clinical cancer research (15.07.2014)
Get full text
Journal Article
A Population Pharmacokinetic and Pharmacodynamic Analysis of Abemaciclib in a Phase I Clinical Trial in Cancer Patients
Tate, Sonya C., Sykes, Amanda K., Kulanthaivel, Palaniappan, Chan, Edward M., Turner, P. Kellie, Cronier, Damien M.
Published in Clinical pharmacokinetics (01.03.2018)
Published in Clinical pharmacokinetics (01.03.2018)
Get full text
Journal Article
A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced Cancer
Michael, Michael, Bang, Yung-Jue, Park, Young Suk, Kang, Yoon-Koo, Kim, Tae Min, Hamid, Oday, Thornton, Donald, Tate, Sonya C., Raddad, Eyas, Tie, Jeanne
Published in Targeted oncology (01.08.2017)
Published in Targeted oncology (01.08.2017)
Get full text
Journal Article
Optimising the combination dosing strategy of abemaciclib and vemurafenib in BRAF-mutated melanoma xenograft tumours
Tate, Sonya C, Burke, Teresa F, Hartman, Daisy, Kulanthaivel, Palaniappan, Beckmann, Richard P, Cronier, Damien M
Published in British journal of cancer (15.03.2016)
Published in British journal of cancer (15.03.2016)
Get full text
Journal Article
Abstract CT019: Population pharmacokinetics of an aurora kinase A inhibitor, LY3295668 erbumine (AK-01), in patients with locally advanced or metastatic solid tumors
Yuen, Eunice, Hui, Yu-Hua, Peña, Amparo de la, Tate, Sonya C., Stille, John R., Lithio, Andrew, Smith, Patricia S., Chu, Quincy, Batist, Gerald, Bouganim, Nathaniel, Fortier, Caroline, Zaknoen, Sara, Kremer, Jill
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Phase 1 study of LY3022855, a colony-stimulating factor-1 receptor (CSF-1R) inhibitor, in patients with metastatic breast cancer (MBC) or metastatic castration-resistant prostate cancer (MCRPC)
Autio, Karen A., Klebanoff, Christopher Austin, Schaer, David, Kauh, John S., Slovin, Susan F., Blinder, Victoria Susana, Comen, Elizabeth Anne, Danila, Daniel Costin, Hoffman, David M. J., Kang, Suhyun, McAndrew, Philomena, Modi, Shanu, Morris, Michael J., Rathkopf, Dana E., Sanford, Rachel Ann, Tate, Sonya C., Yu, Danni, McArthur, Heather L.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article